Back to ABIVAXInsider 
Company
Sylvie Grégoire — ABIVAX
Filing 2026DD1127138Published 16 Jul 2026France public disclosures
InitialEffective
Summary
Sylvie Grégoire
Présidente du Conseil d'Administration
ABIVAX
Last 12 months
- Transactions
- Not available
- Total reported value
- Not available
CompanyABIVAX
ISINFR0012333284
Last 12 months
- Transactions
- Not available
- Total reported value
- Not available
Reported buys
€0.00
Reported sales
€407,928.15
Net buy/sell
-€407,928.15
Other reported value
€0.00
Gross reported value
€407,928.15
Transactions
1
Transactions
| Execution date | Direction | Nature | Instrument | Settlement | Quantity | Unit price | Total | Venue |
|---|---|---|---|---|---|---|---|---|
| 14 Jul 2026 | SellCession / SELL | DISPOSAL | SHARE | UNKNOWN | 3,375 | €120.87 | €407,928.15 | XPAR |
Sell
Execution date14 Jul 2026Cession / SELL
DISPOSAL · SHARE · UNKNOWN · XPAR
- Quantity
- 3,375
- Unit price
- €120.87
- Total
- €407,928.15
Evidence
- AMF · France2026DD1127138
Corrections
Identify the affected field and a source that supports the correction. Use the private contact for rights requests; do not attach identity documents unless necessary and requested.